LSTA

Lisata Therapeutics, Inc.

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Jim SimonsRenaissance Technologies
$660k131.7k shares
AddQ1 2026
$430k
$5.01
$3.30
Jim SimonsRenaissance Technologies
$230k123.7k shares
ExitQ4 2025
$306k
$1.86
$3.30
Jim SimonsRenaissance Technologies
$230k123.7k shares
TrimQ4 2025
$75k
$1.86
$3.30
Jim SimonsRenaissance Technologies
$7.5K
AddQ3 2025
$7.5k
--
$3.30
Jim SimonsRenaissance Technologies
$7.5K
AddQ3 2025
$7.5k
--
$3.30
Jim SimonsRenaissance Technologies
$56.7K
AddQ2 2025
$57k
--
$3.30

News

globenewswire.comHalper Sadeh LLC is Investigating Whether SILA and LSTA are Obtaining Fair Deals for their Shareholdersglobenewswire.comMay 4globenewswire.comURGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—LSTA, IBCP, HCBN, and SILAglobenewswire.comMay 4businesswire.comLeading Financial Trade Associations, Led by LSTA, Submit Amicus Brief in Support of Defendant Lenders in Antitrust Case Filed by Optumum Communicationsbusinesswire.comMar 26proactiveinvestors.comLisata Therapeutics to be acquired by Kuva Labsproactiveinvestors.comMar 9prnewswire.comShareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholdersprnewswire.comMar 9